Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma Approval based on multiple studies, including the pivotal…
MINNEAPOLIS, June 18, 2026 (GLOBE NEWSWIRE) -- NMDP, a global nonprofit leader in cell therapy, announced a new partnership with…
-- Presentations highlight new clinical, real-world, and patient-centered insights on metreleptin across lipodystrophy populations -- June 18, 2026 10:19 ET…
Photo: Arda Güler via FL Comms ISTANBUL, June 18, 2026 (GLOBE NEWSWIRE) -- Medicana Health Group, one of Türkiye’s leading…
Whitby, Ontario, June 17, 2026 (GLOBE NEWSWIRE) -- Ontario Shores Centre for Mental Health Sciences (Ontario Shores) announced today that…
First and only oral carbapenem antibiotic approved in the USApproval based on PIVOT-PO trial demonstrating non-inferiority compared to intravenous treatmentiMore…
Minutes of the TME Pharma Annual General Meeting Berlin, Germany, June 17, 2026, 6:30 p.m. CET – TME Pharma N.V.…
Grand Cayman, June 16, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering…
Fort Worth, TX, June 16, 2026 (GLOBE NEWSWIRE) -- Academic stress has long been considered the defining challenge for K-12…
June 16, 2026 16:15 ET | Source: Cronos Group Inc. TORONTO, June 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc.…